<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Have you ever experienced unusual vaginal discharge that seems heavier than usual, has an unpleasant odor, or noticed spotting between menstrual periods? Many women assume these symptoms are simply caused by stress, hormonal changes, fatigue, or minor infections that will go away on their own. The same is true for mild pelvic pain or bleeding after sexual intercourse, which are often dismissed as harmless issues. However, some of these seemingly common symptoms can actually be early warning signs of cervical cancer that often go unnoticed.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer is one of the most common cancers affecting women and is frequently diagnosed at a later stage because its early symptoms tend to be subtle, mild, or sometimes absent altogether. Many women only realize something is wrong when symptoms become more frequent or begin to interfere with their daily activities. So, what are the early signs of cervical cancer, and why are they often overlooked?Why Are Cervical Cancer Symptoms Often Overlooked?<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">The cervix is located deep inside the reproductive tract and cannot be seen from the outside. Cervical cancer usually develops slowly and is most often caused by a persistent infection with Human Papillomavirus (HPV), which can remain in the body for years without causing noticeable symptoms. In Stage 0, abnormal cells are confined to the surface of the cervix and typically cause no symptoms at all. During Stage 1, symptoms are often very mild and may include unusual vaginal discharge, changes in discharge color or odor, or light pink spotting after sexual intercourse. Because these symptoms can resemble hormonal changes, fatigue, or minor infections, many women do not consider them a serious concern and delay seeking medical attention.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">As the disease progresses, symptoms usually become more noticeable. In Stages 2 and 3, women may experience abnormal vaginal bleeding, foul-smelling or blood-stained discharge, pelvic pain, and pain during intercourse. By Stage 4, the cancer may spread to nearby or distant organs such as the bladder, rectum, lungs, or liver, leading to more severe symptoms including intense pain, urinary problems, swelling, and significant decline in overall health. This is why it is important not to ignore persistent or recurring changes in your body, even if they initially seem minor.Lack of Screening Leads to Delayed Diagnosis<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Another major reason cervical cancer is often detected late is the low awareness of routine cervical cancer screening. Many women believe that tests such as Pap smears or HPV DNA tests are only necessary when symptoms appear. As a result, many cases are not identified until abnormal bleeding, pelvic pain, or other signs indicate that the disease has already progressed to a more advanced stage.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">According to leading health organizations such as the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and the National Cancer Institute (NCI), the progression from HPV infection to cervical cancer is typically very slow, often taking 10–20 years or even longer. This extended timeline provides a valuable opportunity for early detection. Routine screening can identify HPV infections and abnormal cervical cell changes long before they develop into cancer. However, fear, embarrassment, limited health education, lack of access to healthcare, and the belief that “no symptoms means no problem” continue to prevent many women from getting screened regularly.Why Is Routine Screening Important for Early Detection?<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">The World Health Organization recommends regular cervical cancer screening for women between the ages of 30 and 65 because abnormal cervical cell changes can develop silently over many years. Routine screening helps detect HPV infections and precancerous changes at an early stage, allowing treatment before they progress into cervical cancer. Early detection through screening can significantly improve treatment outcomes, reduce the risk of cancer spread, and minimize the need for more complex treatments in advanced stages.Conclusion<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer is often diagnosed late because its early symptoms are mild, subtle, and frequently resemble common reproductive health concerns. As a result, many women remain unaware of abnormal changes occurring in the cervix until the disease has progressed to a more advanced stage. For this reason, it is important not to ignore unusual symptoms and to prioritize regular cervical cancer screening, particularly through HPV DNA testing and Pap smears. Early detection plays a crucial role in identifying HPV infections and abnormal cervical cells before they develop into cervical cancer.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">As a diagnostic laboratory, KALGen Innolab is committed to supporting cervical cancer prevention and early detection through comprehensive screening services, including HPV DNA testing and liquid-based Pap smears. Supported by advanced diagnostic technology and experienced healthcare professionals, KALGen Innolab helps provide more accurate cervical cancer screening and risk assessment. Regular screening can be an important step in protecting women’s reproductive health and improving the chances of successful treatment through early intervention.References<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">American Cancer Society. (2023). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer signs and symptoms<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">. American Cancer Society.<a href="https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/signs-and-symptoms.html" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/signs-and-symptoms.html</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Bio Farma. (2023). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Pentingnya skrining kanker serviks<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">.<a href="https://www.biofarma.co.id/id/announcement/detail/pentingnya-skrining-kanker-serviks" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.biofarma.co.id/id/announcement/detail/pentingnya-skrining-kanker-serviks</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">BMC Women's Health. (2023). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Awareness and barriers to cervical cancer screening among women<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">.<a href="https://bmcwomenshealth.biomedcentral.com/" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://bmcwomenshealth.biomedcentral.com/</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">National Cancer Institute. (n.d.). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer screening<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">. Retrieved May 28, 2026, from<a href="https://www.cancer.gov/types/cervical/screening" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.gov/types/cervical/screening</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">National Cancer Institute. (n.d.). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer symptoms and causes<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">.<a href="https://www.cancer.gov/types/cervical" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.gov/types/cervical</a>World Health Organization. (2024). Cervical cancer.<a href="https://www.who.int/news-room/fact-sheets/detail/cervical-cancer"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.who.int/news-room/fact-sheets/detail/cervical-cancer</a>

Keputihan tidak biasa, bercak darah, atau nyeri panggul sering dianggap sepele. Cari tahu mengapa kanker serviks sering terlambat terdeteksi dan bagaimana skrining rutin dapat membantu menemukannya lebih awal.

Unusual discharge, spotting, or pelvic pain may seem harmless. Discover why cervical cancer often goes undetected and how regular HPV and Pap smear screening can help identify it earlier.

Merasa Baik-Baik Saja? Ini Alasan Kanker Serviks Sering Terlambat Ditemukan

Feeling Fine? Why Cervical Cancer Often Goes Undetected for Years

Mengapa Kanker Serviks Sering Terlambat Terdeteksi?

Why Is Cervical Cancer Often Detected Too Late? Understanding the Silent Warning Signs

<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Have you ever taken an HPV test and felt worried when the result came back positive? That's completely understandable. Many people assume that a positive HPV test automatically means cervical cancer. However, a positive HPV result does not necessarily mean that someone has cancer. Human Papillomavirus (HPV) is a very common virus that can infect anyone who is sexually active. In many cases, HPV infections clear on their own without causing symptoms or developing into cancer.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">So, why should a positive HPV result still be taken seriously? Before panicking or assuming the worst, it is important to understand how HPV infection works and when it may require closer attention.Does a Positive HPV Test Mean Cancer?<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Receiving a positive HPV test result can be concerning, especially since Human Papillomavirus (HPV) is known to be the leading cause of most cervical cancer cases. However, a positive HPV result does not mean that a person already has cervical cancer. It simply indicates the presence of a high-risk HPV type that may cause abnormal changes in cervical cells if the infection persists for a long period of time. HPV is extremely common and is frequently found in sexually active individuals. In most cases, the body's immune system can clear the infection naturally without causing cancer or precancerous cell changes.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">For this reason, a positive HPV result is usually followed by additional evaluations, such as colposcopy, a Pap smear, or a repeat HPV DNA test within 6 to 12 months. These follow-up examinations help determine whether the HPV infection has started to cause abnormal changes in cervical cells. The earlier these changes are detected, the greater the opportunity for treatment before cervical cancer develops. Therefore, the most important step after receiving a positive HPV result is not to panic, but to understand the result correctly and follow your healthcare provider’s recommendations for monitoring.Can HPV Infection Go Away on Its Own?<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Most Human Papillomavirus (HPV) infections clear on their own without requiring specific treatment. Once the virus enters the body, the immune system works to fight and eliminate the infection naturally. According to the World Health Organization (WHO), approximately 90% of HPV infections resolve within one to two years without causing serious health problems. This is why a positive HPV test does not automatically mean that someone will develop cervical cancer or precancerous lesions.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">However, not all HPV infections disappear on their own. In some women, particularly those infected with high-risk HPV types or those with weakened immune systems, the virus can persist for many years. Persistent HPV infection may lead to abnormal cervical cell changes known as precancerous lesions, which can eventually develop into cervical cancer if left untreated. Therefore, even though most HPV infections clear naturally, follow-up testing and routine monitoring remain essential to ensure the infection does not progress into a more serious condition.Is Follow-Up Monitoring Still Necessary?<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Although most HPV infections can resolve on their own, a positive HPV test result should never be ignored. In some women, especially those with high-risk HPV infections, the virus can remain in the body for years and cause abnormal cervical cell changes without producing obvious symptoms. This is why ongoing monitoring is important to confirm that the infection has cleared and has not progressed into precancerous changes or cervical cancer.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Healthcare providers may recommend regular follow-up examinations, such as repeat HPV DNA testing, Pap smears, or other assessments based on individual screening results and risk factors. Routine monitoring is important because cervical cell changes often develop gradually and can be identified before they progress into cervical cancer. By following the recommended screening schedule, the risk of delayed diagnosis can be reduced and the chances of successful treatment can be significantly improved.Conclusion<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">A positive HPV test result does not necessarily mean that a person has cervical cancer. In many cases, HPV infections are cleared naturally by the immune system without causing serious health problems. However, because certain high-risk HPV types can persist in the body and trigger abnormal cervical cell changes, a positive HPV result should still be taken seriously. Follow-up testing and regular monitoring play an important role in ensuring that the infection does not progress into precancerous conditions or cervical cancer. With proper screening and monitoring, potential risks can be identified early, allowing for timely and effective intervention.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">As a diagnostic laboratory, KALGen Innolab is committed to supporting cervical cancer prevention and early detection through comprehensive screening services, including HPV DNA testing and Pap smears. Supported by advanced diagnostic technology and experienced healthcare professionals, KALGen Innolab helps provide accurate cervical health screening and monitoring. Regular examinations based on medical recommendations can be an important step in identifying risks early and maintaining long-term reproductive health.References<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">American Cancer Society. (2023). <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">The American Cancer Society guidelines for the prevention and early detection of cervical cancer<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">.<a href="https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html" style="text-decoration:none;"><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html</a><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">American Cancer Society. (2023). <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">What causes cervical cancer?<a href="https://www.cancer.org/cancer/types/cervical-cancer/causes-risks-prevention/what-causes.html" style="text-decoration:none;"><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.org/cancer/types/cervical-cancer/causes-risks-prevention/what-causes.html</a><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">National Cancer Institute. (n.d.). <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">HPV and Pap testing<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">. Retrieved June 3, 2026, from<a href="https://www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet" style="text-decoration:none;"><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet</a><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">National Cancer Institute. (n.d.). <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer screening<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">. Retrieved June 3, 2026, from<a href="https://www.cancer.gov/types/cervical/screening" style="text-decoration:none;"><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.gov/types/cervical/screening</a><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">World Health Organization. (2021). <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> (2nd ed.).<a href="https://www.who.int/publications/i/item/9789240030824" style="text-decoration:none;"><span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.who.int/publications/i/item/9789240030824</a>

Tes HPV positif sering menimbulkan kepanikan. Namun, apakah hasil tersebut berarti kanker serviks? Ketahui fakta penting tentang HPV, risiko kanker, dan langkah selanjutnya yang perlu dilakukan.

Received a positive HPV test result? Before assuming the worst, learn what it really means, your cancer risk, and the next steps recommended by healthcare professionals.

Tes HPV Positif? Jangan Panik, Belum Tentu Kanker Serviks

HPV Test Positive? It Doesn't Always Mean Cervical Cancer

Jika Hasil Tes HPV Positif, Apakah Berarti Kanker?

What Does a Positive HPV Test Really Mean?

<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer remains one of the most common cancers affecting women and is often only detected after reaching an advanced stage because it may not cause symptoms in the early stages. This is why early detection plays an important role in identifying changes in the cervix before they develop into cancer. Pap smears and HPV DNA tests are two of the most commonly used screening methods for cervical cancer. However, many people still assume that they are the same test, even though Pap smears and HPV DNA tests have different functions and methods of detecting cervical cancer risk. So, what exactly is the difference between a Pap smear and an HPV DNA test?What Is a Pap Smear and How Does It Help Detect Cervical Cancer?<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">A Pap smear is one of the most widely used methods for early cervical cancer screening. The term “Pap smear” comes from “Pap” and “smear.” “Pap” refers to Papanicolaou staining, a special staining method used to make cervical cell samples easier to examine under a microscope by an anatomical pathologist. During the procedure, a sample of cells is collected from the cervix (cervical swab) to check for abnormal cell changes or precancerous conditions that may develop into cervical cancer. Detecting abnormal cells early allows treatment to begin before the condition progresses into a more serious stage.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Pap smears are commonly used because the procedure is relatively simple, widely available, and has long been recommended for cervical cancer screening. However, this test also has limitations because the results depend on whether abnormal cell changes have already occurred in the cervix. In other words, a Pap smear detects the effects of abnormal cell changes, but it does not directly detect Human Papillomavirus (HPV), the main cause of most cervical cancer cases. With advances in molecular diagnostic technology, HPV viral DNA can now be detected through HPV DNA testing.What Is an HPV DNA Test and How Does It Detect Cervical Cancer?<span style="font-size:11pt;font-family:Nunito,sans-serif;color:#000000;background-color:transparent;font-weight:400;font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre;white-space:pre-wrap;">The HPV DNA test is considered a more modern cervical cancer screening method because it detects high-risk Human Papillomavirus (HPV), the virus responsible for most cervical cancer cases. Unlike a Pap smear, which focuses on abnormal cervical cell changes, the HPV DNA test identifies whether high-risk HPV infection is present, even before abnormal cell changes occur. Around 15 high-risk HPV subtypes can be detected through this test, including HPV types 16 and 18, which are most strongly associated with cervical cancer. In addition to detecting risk earlier than a Pap smear, HPV DNA testing is also considered more accurate than conventional cervical cytology tests and does not rely on microscopic interpretation by an anatomical pathology specialist.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">The sample collection process is similar to a Pap smear, using a cervical swab to collect cervical mucus cells. The sample is then analyzed in a laboratory to detect the genetic material (DNA) of high-risk HPV. Because it directly identifies the main cause of cervical cancer, HPV DNA testing has higher sensitivity compared to Pap smears in cervical cancer screening. This allows women at higher risk to be identified earlier so that monitoring and treatment can begin sooner.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">However, a positive HPV result does not automatically mean someone has or will definitely develop cervical cancer, since most HPV infections can clear naturally through the immune system. For this reason, test results should still be evaluated together with other examinations and medical consultation. Based on recommendations from the World Health Organization (WHO) and the American Cancer Society (ACS), HPV DNA screening is generally recommended starting at age 30 and can be performed every five years for women with average risk. In certain situations, such as abnormal screening results, weakened immunity, or previous HPV infection, testing may be recommended earlier or more frequently according to a doctor’s advice.The Difference Between Pap Smear and HPV DNA Testing<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Although both are used for cervical cancer screening, Pap smears and HPV DNA tests focus on different aspects of detection. A Pap smear is designed to identify abnormal cell changes in the cervix that may develop into cancer. Meanwhile, the HPV DNA test detects high-risk Human Papillomavirus (HPV), the primary cause of most cervical cancer cases. Simply put, a Pap smear looks for the “effect” on cervical cells, while an HPV DNA test identifies the “cause,” namely HPV infection.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Pap smears have long been proven effective in detecting precancerous and cancerous cervical cell changes. However, HPV DNA testing is considered more sensitive and can detect cervical cancer risk earlier because it identifies HPV infection before abnormal cell changes appear. This allows the risk of cervical cancer to be recognized sooner, enabling earlier monitoring and treatment. Even so, both tests still play important roles and, in some cases, may be used together to improve the effectiveness of cervical cancer screening.Conclusion<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Understanding the difference between a Pap smear and an HPV DNA test can help women choose the most appropriate cervical cancer screening method based on their individual needs and conditions. Pap smears focus on detecting abnormal cervical cell changes, while HPV DNA testing identifies high-risk HPV infection as the main cause of cervical cancer. Although the two tests have different functions, both play an important role in early detection and can help identify cervical cancer risk before it progresses further.<span style="font-size: 11pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">As a diagnostic laboratory, KALGen Innolab is committed to supporting cervical cancer prevention and early detection through comprehensive screening services, including Pap smear and HPV DNA testing. Supported by advanced diagnostic technology and experienced medical professionals, KALGen Innolab helps provide more accurate cervical cancer screening and risk assessment. Early detection through the right screening method is an important step in improving the effectiveness of cervical cancer prevention and treatment.References<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">American Cancer Society. (2023). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">The American Cancer Society guidelines for the prevention and early detection of cervical cancer<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">.<a href="https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.org/cancer/types/cervical-cancer/detection-diagnosis-staging/cervical-cancer-screening-guidelines.html</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">National Cancer Institute. (n.d.). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">HPV and Pap testing<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">. Retrieved May 15, 2026, from<a href="https://www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">World Health Organization. (2021). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> (2nd ed.).<a href="https://www.who.int/publications/i/item/9789240030824" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.who.int/publications/i/item/9789240030824</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">World Health Organization. (2024). <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Cervical cancer<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">.<a href="https://www.who.int/news-room/fact-sheets/detail/cervical-cancer" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://www.who.int/news-room/fact-sheets/detail/cervical-cancer</a><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Wright, T. C., Stoler, M. H., Behrens, C. M., Sharma, A., Zhang, G., &amp; Wright, T. L. (2015). Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test. <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: italic; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">Gynecologic Oncology, 136<span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;">(2), 189–197.<a href="https://doi.org/10.101" style="text-decoration:none;"><span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(0, 0, 0); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: none; vertical-align: baseline; white-space: pre-wrap;"> <span style="font-size: 10pt; font-family: KalbeSerif; color: rgb(17, 85, 204); background-color: transparent; font-weight: 400; font-style: normal; font-variant: normal; text-decoration: underline; text-decoration-skip-ink: none; vertical-align: baseline; white-space: pre-wrap;">https://doi.org/10.101</a>

Masih bingung memilih Pap smear atau tes HPV DNA? Kenali perbedaan fungsi, cara kerja, kelebihan, hingga akurasi kedua pemeriksaan untuk deteksi dini kanker serviks.

Confused about Pap smears and HPV DNA tests? Learn the differences, accuracy, benefits, and how each test helps detect cervical cancer early.

Pap Smear vs Tes HPV DNA: Apa Bedanya dan Mana yang Lebih Akurat?

Pap Smear vs HPV DNA Test: What’s the Difference and Which Is More Accurate?

Pap Smear & Tes HPV DNA: Apa Bedanya?

Pap Smear vs HPV DNA Test: What’s the Difference?

Masih bingung membedakan kanker serviks dan kanker rahim? Ketahui perbedaan lokasi, penyebab, faktor risiko, gejala, hingga cara mencegah kanker serviks dan kanker rahim.

Confused about cervical cancer and uterine cancer? Learn the differences in causes, symptoms, risk factors, and ways to help prevent cervical and uterine cancer.

Apa Itu Kanker Serviks? Bedanya dengan Kanker Rahim

What Is Cervical Cancer? How Is It Different from Uterine Cancer?

Apa Itu Kanker Serviks? Apakah sama dengan Kanker Rahim?

What Is Cervical Cancer? Is It the Same as Uterine Cancer?

Genetik atau gaya hidup, mana yang lebih berpengaruh pada kanker? Simak penjelasan lengkap tentang risiko dan cara menguranginya.

Genetics or lifestyle, which plays a bigger role in cancer? Discover the facts, risks, and practical ways to lower your chances.

Genetik dan Gaya Hidup: Mana Penyebab Kanker yang Lebih Berpengaruh?

Genetics and Lifestyle: What Causes Cancer the Most?

Kanker: Warisan Genetik atau Konsekuensi Gaya Hidup?

Cancer: Genetics or Lifestyle, What Really Matters?

Banyak yang langsung overthinking soal kanker turunan. Padahal, faktanya tidak sesederhana itu. Simak penjelasan medisnya di sini.

Thinking cancer is always inherited? Not that easy. Discover the real facts about genetic risk in a clear and reassuring way.

Kanker Turunan? Jangan Ovethinking dulu! Ini Penjelasannya

Worried About Hereditary Cancer? Don’t Panic, Know the Facts

Apakah Semua Jenis Kanker Bisa Diturunkan?

Can All Types of Cancer Be Inherited?

Apakah kanker darah bisa diturunkan? Kenali hubungan faktor keturunan, gejala, penyebab, serta langkah deteksi dini dan penanganannya.

Can blood cancer be inherited? Learn about hereditary risk factors, symptoms, causes, early detection, and treatment options.

Kanker Darah karena Faktor Keturunan? Gejala, Penyebab & Risiko

Hereditary Blood Cancer: Symptoms, Causes & Risk Factors

Mengenal Kanker Darah yang Berkaitan dengan Faktor Keturunan

Understanding Blood Cancer Linked to Hereditary Factors

Apakah kanker payudara bisa diturunkan? Kenali perbedaan kanker turunan dan sporadik, peran gen BRCA, serta risiko jika ada riwayat keluarga.

Is breast cancer hereditary? Learn the difference between inherited and sporadic cases, BRCA gene risks, and what family history means for you.

Apakah Kanker Payudara Bisa Diturunkan? Ini Penjelasan Lengkapnya

Is Breast Cancer Hereditary? Key Facts About Genetic Risk

Apakah Kanker Payudara Bisa Diturunkan? Ini Penjelasan yang Perlu Anda Tahu

Is Breast Cancer Hereditary? What You Need to Know

Apakah kanker bisa diturunkan? Pahami perbedaan risiko dan kepastian, faktor genetik, serta pentingnya tes genetik untuk deteksi dini kanker.

Is cancer hereditary? Learn the difference between risk and certainty, genetic factors, and the role of genetic testing for early detection.

Apakah Kanker Orang Tua Pasti Menurun ke Anak?

If a Parent Has Cancer, Will the Child Inherit It?

Jika Orang Tua Mengidap Kanker, Apakah Anak Pasti Terkena?

If a Parent Has Cancer, Will the Child Definitely Get It?

Pahami mutasi EGFR pada kanker paru, mulai dari gejala, penyebab, pemeriksaan, hingga terapi target untuk meningkatkan efektivitas pengobatan.

Understand EGFR mutation in lung cancer, including symptoms, causes, diagnostic tests, and targeted therapy options to improve treatment outcomes.

Apa Itu Mutasi EGFR pada Kanker Paru? Penyebab, Tes & Pengobatan

What Is EGFR Mutation in Lung Cancer? Causes, Testing & Treatment

Apa Itu Mutasi EGFR pada Kanker Paru?

What Is an EGFR Mutation in Lung Cancer?

Skrining kanker paru dengan LDCT membantu deteksi dini sebelum gejala muncul. Ketahui siapa yang direkomendasikan menjalani pemeriksaan, manfaat, serta risikonya untuk keputusan yang lebih tepat.

LDCT lung cancer screening enables early detection before symptoms appear. Learn who should get screened, along with its benefits and risks, to make informed health decisions.

Skrining Kanker Paru dengan LDCT: Siapa yang Perlu & Manfaatnya

LDCT Lung Cancer Screening: Who Needs It & Key Benefits

Skrining Kanker Paru: Siapa yang Perlu Low-Dose CT Scan? (LDCT)

Lung Cancer Screening: Who Needs a Low-Dose CT Scan (LDCT)?

Batuk berkepanjangan bisa jadi tanda serius. Kenali perbedaan gejala kanker paru dan TBC serta pentingnya deteksi dini untuk penanganan yang lebih efektif.

A persistent cough may be more than just a minor issue. Learn how to distinguish lung cancer symptoms from tuberculosis (TB) and why early detection is crucial for effective treatment.

Batuk Tak Sembuh? Kenali Gejala Kanker Paru & Bedanya dengan TBC

Persistent Cough? Early Signs of Lung Cancer You Shouldn’t Ignore

Batuk Tak Kunjung Sembuh? Waspadai Gejala Kanker Paru

Still Coughing? Don’t Ignore These Possible Lung Cancer Symptoms

Kenali perbedaan TBC dan kanker paru dari gejala, penyebab, hingga metode diagnosis agar tidak salah penanganan.

Understand the differences between tuberculosis (TB) and lung cancer, including symptoms, causes, and diagnosis to avoid misdiagnosis.

Perbedaan TBC dan Kanker Paru: Gejala, Penyebab, dan Diagnosis

Tuberculosis vs Lung Cancer: Differences in Symptoms, Causes, and Diagnosis

Sering Disalahartikan, Apa Bedanya TBC dan Kanker Paru?

Often Misinterpreted: What’s the Difference Between Tuberculosis (TB) and Lung Cancer?

Apakah kanker payudara stadium awal selalu membutuhkan kemoterapi? Ketahui risiko kekambuhan, peran tes genomik, dan pilihan terapi yang lebih personal.

Do patients with early-stage breast cancer always need chemotherapy? Learn about recurrence risk, the role of genomic testing, and more personalized treatment options.

Apakah Kanker Payudara Stadium Awal Selalu Butuh Kemoterapi?

Do Early-Stage Breast Cancer Patients Always Need Chemotherapy?

Kanker Payudara Stadium Awal: Apakah Selalu Perlu Kemoterapi?

Early-Stage Breast Cancer: Is Chemotherapy Always Necessary?

Kanker paru sering dikaitkan dengan perokok. Namun, penyakit ini juga dapat terjadi pada non-perokok akibat faktor seperti polusi udara, asap rokok pasif, dan faktor genetik.

Lung cancer is often associated with smoking, but it can also affect non-smokers. Learn about other risk factors such as air pollution, secondhand smoke, and genetics.

Kanker Paru: Tidak Hanya Terjadi pada Perokok

Lung Cancer: Not Only Occurring in Smokers

Lung Cancer Isn’t Just a Smoker’s Disease

Kenali hubungan gen BRCA dengan risiko kanker payudara dan ovarium. Siapa yang perlu melakukan tes genetik dan bagaimana cara mengidentifikasi risiko sejak dini?

Learn about the relationship between BRCA genes and breast and ovarian cancer risk. Who should undergo genetic testing, and how can you identify risk early?

Apakah Anda Perlu Tes Genetik BRCA? Ini Penjelasannya

Do You Need a BRCA Genetic Test? Here's Why

Gen BRCA dan Kanker Payudara: Apakah Anda Perlu Tes Genetik?

BRCA Genes and Breast Cancer: Do You Need Genetic Testing?

Benarkah kanker payudara hanya menyerang wanita dengan riwayat keluarga? Temukan fakta ilmiah yang membongkar mitos, peran gen BRCA1-BRCA2, risiko pada pria & wanita muda, plus tips pencegahan gaya hidup sehat. Pelajari pentingnya skrining rutin & KAL-Screen BRCA dari KALGen Innolab untuk deteksi dini, lindungi diri sekarang!

Does breast cancer only affect women with a family history? This article debunks myths like male breast cancer risk, BRCA1-BRCA2 gene roles, young women cases, and lifestyle prevention tips. Discover why routine screening matters for all explore KALGen Innolab's KAL-Screen BRCA test for early detection and protect your future now!

Benarkah Kanker Payudara Dipengaruhi Riwayat Keluarga?

Benarkah Kanker Payudara Hanya Terjadi pada Wanita dengan Riwayat Keluarga?

Does Breast Cancer Only Affect Women with a Family History?

Apakah menyusui dapat menurunkan risiko kanker payudara? Simak penjelasan ilmiah, mekanismenya, dan faktor lain yang memengaruhi risiko

Can breastfeeding reduce the risk of breast cancer? Learn about the scientific explanation, mechanisms, and other factors that influence risk

Apakah Menyusui Turunkan Risiko Kanker Payudara?

Does Breastfeeding Lower the Risk of Breast Cancer?

Benarkah Menyusui Mencegah Kanker Payudara?

Can Breastfeeding Reduce the Risk of Breast Cancer?

Menemukan benjolan di payudara? Ketahui penyebabnya, tanda bahaya yang perlu diwaspadai, dan kapan sebaiknya segera memeriksakan diri ke dokter

Found a breast lump? Learn the possible causes, warning signs to watch for, and when you should see a doctor for further evaluation

Kapan Benjolan di Payudara Perlu Diperiksa?

When Should a Breast Lump Be Checked?

Benjolan di Payudara: Kapan Harus Khawatir?

A Lump in the Breast: When Is It a Cause for Concern?

Jakarta, 13 Desember 2025 — Perkembangan teknologi diagnostik
molekuler terus mendorong perubahan paradigma dalam tata laksana kanker,
khususnya dalam pemantauan penyakit setelah terapi kuratif. Salah satu inovasi
yang kini semakin mendapat perhatian adalah Minimal Residual Disease (MRD),
yaitu deteksi sisa sel kanker yang tidak lagi teridentifikasi melalui
pemeriksaan radiologi atau patologi konvensional.<o:p></o:p>Menjawab kebutuhan akan pemahaman
klinis yang lebih komprehensif, KALGen Academia menyelenggarakan webinar
ilmiah bertajuk “Clinical Impact of MRD Results”. Webinar ini
menghadirkan diskusi mendalam mengenai pemanfaatan pemeriksaan MRD berbasis circulating
tumor DNA (ctDNA) menggunakan teknologi Next Generation Sequencing (NGS),
serta bagaimana hasilnya dapat diinterpretasikan untuk mendukung pengambilan
keputusan terapi yang lebih presisi dan berbasis bukti.<o:p></o:p>Webinar ini menghadirkan dua
narasumber, yaitu Dr. Yongjun Cha (Former Medical Oncologist,
National Cancer Centre Korea) yang membawakan materi pertama berjudul “Detecting
the Invisible: ctDNA in Minimal Residual Disease Monitoring”, serta dr.
Trinugroho Heri Fadjari, Sp.PD, KHOM yang menyampaikan materi kedua
berjudul “MRD Testing: Guiding Precision in Cancer Care”. Kedua
narasumber memaparkan aspek ilmiah serta aplikasi klinis pemeriksaan MRD secara
komprehensif dan aplikatif. Diskusi ilmiah dalam webinar ini dipandu oleh Dr.
dr. Jeffry Beta Tenggara, Sp.PD, KHOM, yang mengarahkan sesi tanya jawab
serta memperkaya pembahasan dengan perspektif klinis yang relevan dengan
praktik sehari-hari.<o:p></o:p>Webinar ini diikuti oleh sekitar 100
peserta, yang sebagian besar merupakan dokter spesialis penyakit dalam
konsultan hematologi-onkologi medik (Sp.PD, K-HOM) dari berbagai daerah di
Indonesia. Selain itu, kegiatan ini juga dihadiri oleh dokter, klinisi,
patolog, serta berbagai pihak lain yang memiliki ketertarikan dalam
pengembangan dan pemutakhiran ilmu pengetahuan mengenai diagnostik molekuler
dalam praktik klinis.<o:p></o:p>&nbsp;MRD: Mengungkap Penyakit yang Tidak
Terlihat<o:p></o:p>Pada banyak kasus kanker padat, pasien
dapat mencapai complete response setelah pembedahan atau terapi
sistemik. Namun, risiko kekambuhan tetap ada akibat keberadaan sel kanker
mikroskopik yang tidak terdeteksi dengan metode standar. Pemeriksaan MRD berbasis
ctDNA memungkinkan deteksi sisa penyakit tersebut melalui analisis
fragmen DNA tumor yang beredar dalam darah.<o:p></o:p>Dengan dukungan teknologi Next
Generation Sequencing (NGS), pemeriksaan MRD mampu memberikan sensitivitas
tinggi dalam mendeteksi perubahan molekuler tumor. Pendekatan ini tidak hanya
berperan dalam pemantauan respons terapi, tetapi juga sebagai alat prediktif
untuk menilai risiko kekambuhan lebih awal, bahkan sebelum muncul manifestasi
klinis.<o:p></o:p>Dari Hasil Laboratorium ke Keputusan
Klinis<o:p></o:p>Dalam webinar ini dibahas bahwa nilai
utama pemeriksaan MRD tidak hanya terletak pada kemampuan deteksinya, tetapi
pada bagaimana hasil tersebut diterjemahkan menjadi tindakan klinis.
Hasil MRD dapat memberikan informasi penting dalam berbagai skenario klinis, antara
lain:<o:p></o:p><ul style="margin-top:0in" type="disc">
 <li class="MsoNormal" style="color:black;margin-bottom:0in;margin-bottom:.0001pt;
 text-align:justify;line-height:normal;mso-list:l0 level1 lfo1;tab-stops:
 list .5in;vertical-align:baseline">MRD
 negatif pasca terapi kuratif 
 Mengindikasikan respons
 terapi yang optimal dan risiko kekambuhan yang lebih rendah, sehingga
 pasien dapat dipantau tanpa intervensi tambahan yang tidak perlu.<o:p></o:p></li>
 <li class="MsoNormal" style="color:black;margin-bottom:0in;margin-bottom:.0001pt;
 text-align:justify;line-height:normal;mso-list:l0 level1 lfo1;tab-stops:
 list .5in;vertical-align:baseline">MRD
 positif pasca terapi 
 Menunjukkan adanya sisa penyakit
 molekuler dan peningkatan risiko relaps, yang dapat menjadi dasar
 pertimbangan untuk intensifikasi terapi atau pemantauan lebih ketat.<o:p></o:p></li>
 <li class="MsoNormal" style="color:black;margin-bottom:12.0pt;text-align:justify;
 line-height:normal;mso-list:l0 level1 lfo1;tab-stops:list .5in;vertical-align:
 baseline">Perubahan status MRD selama
 follow-up 
 Kenaikan kadar ctDNA dapat
 menandakan kekambuhan dini, bahkan sebelum terdeteksi melalui imaging,
 sehingga membuka peluang intervensi lebih awal. 
 
  
 <o:p></o:p></li>
</ul>Diskusi ini menegaskan bahwa MRD
berpotensi menjadi alat bantu stratifikasi risiko yang kuat, mendukung konsep
pengobatan yang lebih personal dan presisi dalam penanganan kasus kanker secara
menyeluruh.<o:p></o:p>Komitmen KALGen Academia dalam Edukasi
Onkologi Presisi<o:p></o:p>Melalui webinar ini, KALGen Academia
menegaskan komitmennya sebagai platform edukasi ilmiah yang mendukung
implementasi precision oncology di Indonesia. Dengan menghadirkan
diskusi berbasis bukti ilmiah dan praktik klinis terkini, KALGen Academia
berupaya membantu tenaga medis memahami dan memanfaatkan teknologi diagnostik
molekuler secara optimal demi kepentingan pasien.<o:p></o:p>



























<span style="font-size:11.0pt;line-height:107%;font-family:&quot;Kalbe Helix&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA">Minimal Residual Disease bukan lagi sekadar konsep penelitian, melainkan
alat klinis yang semakin nyata perannya dalam menentukan arah terapi dan
pemantauan pasien kanker. Melalui edukasi berkelanjutan seperti webinar “Clinical
Impact of MRD Results”, KALGen Academia berharap dapat berkontribusi dalam
meningkatkan kualitas pengambilan keputusan klinis serta hasil pengobatan
pasien di era terapi presisi.

Jakarta, December 13, 2025 — Advances in molecular diagnostic
technology continue to reshape the paradigm of cancer management, particularly
in disease monitoring following curative treatment. One innovation that has
gained increasing attention is Minimal Residual Disease (MRD) testing,
which enables the detection of residual cancer cells at the molecular level
that are no longer identifiable through conventional radiological or
pathological examinations.<o:p></o:p>In response to the growing need for
deeper clinical understanding, KALGen Academia organized a scientific
webinar entitled “Clinical Impact of MRD Results.” This webinar provided
an in-depth discussion on the clinical application of MRD testing based on
circulating tumor DNA (ctDNA) using Next Generation Sequencing (NGS)
technology, as well as how MRD results can be interpreted to support more
precise and evidence-based therapeutic decision-making.<o:p></o:p>The webinar featured two distinguished
speakers. Dr. Yongjun Cha (Former Medical Oncologist, National Cancer
Centre Korea) delivered the first presentation entitled “Detecting the
Invisible: ctDNA in Minimal Residual Disease Monitoring.” The second
session was presented by dr. Trinugroho Heri Fadjari, Sp.PD, K-HOM, with
the topic “MRD Testing: Guiding Precision in Cancer Care.” Both speakers
comprehensively addressed the scientific principles and clinical applications
of MRD testing in an informative and practical manner.<o:p></o:p>The scientific discussion was moderated
by Dr. dr. Jeffry Beta Tenggara, Sp.PD, K-HOM, who guided the
question-and-answer session and enriched the discussion with clinically
relevant insights applicable to daily medical practice.<o:p></o:p>The webinar was attended by
approximately 100 participants, the majority of whom were consultant
internists in hematology-oncology (Sp.PD, K-HOM) from various regions
across Indonesia. In addition, the audience included physicians, clinicians,
pathologists, and other stakeholders with a strong interest in advancing and
updating knowledge in molecular diagnostics for clinical practice.<o:p></o:p>MRD: Detecting the Invisible Disease<o:p></o:p>In many solid tumor cases, patients may
achieve a complete response following surgery or systemic therapy.
However, the risk of recurrence often persists due to the presence of
microscopic residual cancer cells that escape detection by standard diagnostic
methods. ctDNA-based MRD testing enables the identification of this
residual disease through the analysis of tumor-derived DNA fragments
circulating in the bloodstream.<o:p></o:p>Supported by Next Generation
Sequencing (NGS) technology, MRD testing offers high sensitivity in
detecting molecular alterations associated with residual disease. Beyond
therapy response monitoring, this approach serves as a powerful predictive tool
for assessing the risk of recurrence at an early stage—often before clinical or
radiological manifestations appear.<o:p></o:p>From Laboratory Results to Clinical
Decision-Making<o:p></o:p>A key message emphasized during the
webinar was that the true value of MRD testing lies not only in its detection
capability, but in how MRD results are translated into clinical action.
MRD findings provide critical information across several clinical scenarios,
including:<o:p></o:p><ul style="margin-top:0in" type="disc">
 <li class="MsoNormal" style="color:black;margin-top:12.0pt;margin-bottom:0in;
 margin-bottom:.0001pt;line-height:normal;mso-list:l0 level1 lfo1;
 tab-stops:list .5in;vertical-align:baseline">MRD-negative status after curative therapy Indicates an optimal therapeutic response
 and a lower risk of recurrence, allowing patients to be monitored without
 unnecessary additional treatment.<o:p></o:p></li>
 <li class="MsoNormal" style="color:black;margin-bottom:0in;margin-bottom:.0001pt;
 line-height:normal;mso-list:l0 level1 lfo1;tab-stops:list .5in;vertical-align:
 baseline">MRD-positive status after
 therapy Suggests the presence of molecular
 residual disease and an increased risk of relapse, serving as a basis for
 considering treatment intensification or closer surveillance.<o:p></o:p></li>
 <li class="MsoNormal" style="color:black;margin-bottom:12.0pt;line-height:normal;
 mso-list:l0 level1 lfo1;tab-stops:list .5in;vertical-align:baseline">Changes in MRD status during follow-up Rising ctDNA levels may signal early
 recurrence, even before detection by imaging, thereby enabling earlier
 clinical intervention.<o:p></o:p></li>
</ul>These discussions reinforced the role
of MRD as a powerful risk stratification tool, supporting more
personalized and precise cancer&nbsp; to improve clinical decision-making and
better patient outcomes in the era of precision medicine.<o:p></o:p>KALGen Academia’s Commitment to
Precision Oncology Education<o:p></o:p>Through this webinar, KALGen
Academia reaffirmed its commitment as a scientific education platform
supporting the implementation of precision oncology in Indonesia. By
facilitating discussions grounded in scientific evidence and current clinical
practice, KALGen Academia aims to empower healthcare professionals to better
understand and optimally utilize molecular diagnostic technologies for the
benefit of patients.<o:p></o:p>



























<span style="font-size:11.0pt;line-height:107%;font-family:&quot;Kalbe Helix&quot;;
mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:Arial;
color:black;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA">Minimal Residual Disease is no longer merely a research concept; it has
become a clinically meaningful tool with a growing impact on therapeutic
direction and patient monitoring. Through continuous educational initiatives
such as the “Clinical Impact of MRD Results” webinar, KALGen Academia
strives to contribute<span style="font-size:12.0pt;line-height:107%;
font-family:&quot;Kalbe Helix&quot;;mso-fareast-font-family:&quot;Times New Roman&quot;;mso-bidi-font-family:
&quot;Times New Roman&quot;;mso-ansi-language:EN-US;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA">.

Ikuti Webinar KALGen Academia membahas Clinical Impact of MRD Results sebagai dasar pengambilan keputusan klinis berbasis data molekuler

Join the KALGen Academia Webinar discussing the Clinical Impact of MRD Results as a basis for data-driven clinical decision-making

Webinar MRD Oncology: Clinical Impact of MRD Results | KALGen Academia

Webinar KALGen Academia “Clinical Impact of MRD Results”: Menjadikan Data Molekuler sebagai Dasar Keputusan Klinis

KALGen Academia Webinar “Clinical Impact of MRD Results”: Transforming Molecular Data into Informed Clinical Decisions

Banyak orang mengalami alergi telur tanpa menyadarinya. Ketahui penyebabnya, gejala tersembunyi, serta pentingnya tes alergi sejak dini

Many people have an egg allergy without realizing it. Learn why it often goes unnoticed, common symptoms, and when to consider allergy testing

Mengapa Banyak Orang Tidak Menyadari Mereka Memiliki Alergi Telur

Why Many People Don’t Know They Have an Egg Allergy

Mengapa Banyak Orang tak Tahu Mereka Alergi Telur? Ini Penjelasannya!

Why Do Many People Not Realize They Are Allergic to Eggs? Here’s the Explanation!

Triple-Negative Breast Cancer (TNBC) adalah jenis kanker payudara yang paling agresif dan sulit diobati. Pelajari kenapa deteksi dini sangat penting sebelum kondisinya berkembang cepat tanpa gejala jelas.

Triple-Negative Breast Cancer (TNBC) is one of the most aggressive breast cancer types. Learn why early detection matters before it progresses quickly without clear symptoms.

Apa Itu Triple‑Negative Breast Cancer (TNBC) dan Kenapa Sulit Diobati?

What Is Triple-Negative Breast Cancer (TNBC) and Why Is It Hard to Treat?

Mengenal peran hormon dalam kanker payudara membantu Anda memahami risiko pribadi dan mengambil tindakan tepat untuk pencegahan maupun deteksi dini.

Knowing the role of hormones in breast cancer helps you assess personal risk and take the right actions for prevention and early detection.

Mengungkap Peran Hormon dalam Kanker Payudara: Wawasan Penting untuk Deteksi dan Pencegahan

Uncovering the Role of Hormones in Breast Cancer: Essential Insights for Prevention

Benjolan di payudara tidak selalu berbahaya, tetapi ada tanda-tanda tertentu yang tidak boleh Anda abaikan. Pelajari cara dokter menilai mana yang harus segera diperiksa dan mana yang aman diamati.

A breast lump isn’t always dangerous, but there are signs you should never ignore. Learn how doctors determine which lumps need urgent evaluation and which are safe to observe.

Kapan Benjolan di Payudara Wajib Diperiksa, dan Kapan Tidak? Ini Penjelasan Dokternya

When Does a Breast Lump Need to Be Checked—and When Does It Not? Here’s the Doctor’s Explanation

Tubuh memberi sinyal lebih awal dari yang kita kira. Pahami tanda-tanda awal mutasi sel payudara dan apa artinya bagi kesehatanmu.

Your body sends signals earlier than you think. Understand the first signs of breast cell mutation and what they mean for your health.

Ketika Tubuh Memulai Perubahan yang Tak Terlihat, Inilah Cerita di Balik Mutasi Sel Payudara

When the Body Begins Invisible Changes, Here’s the Story Behind Breast Cell Mutation

Kelelahan terus-menerus bisa jadi lebih dari sekadar padatnya aktivitas. Kenali kaitan stres dan tidur dengan kanker payudara.

Constant fatigue might mean more than just being busy. Discover the link between stress, sleep, and breast cancer.

Peran Stres dan Tidur dalam Risiko Kanker Payudara yang Sering Diabaikan

The Overlooked Role of Stress and Sleep in Breast Cancer Risk

Apa yang sebenarnya terjadi jika terapi kanker payudara tidak dilakukan? Dalam tulisan ini Anda akan menemukan fakta-fakta mengejutkan, pilihan alternatif, dan bagaimana keputusan Anda hari ini bisa menentukan kualitas hidup Anda di masa depan.

What actually happens if breast cancer therapy is not undertaken? In this article you’ll uncover shocking facts, alternative choices, and how your decision today may define your future quality of life.

Apa yang akan Terjadi Jika Anda Menolak Mengobati Kanker Payudara?

What Will Happen If You Refuse to Treat Breast Cancer?

Selama ini Anda mungkin menghindari makanan tertentu karena takut memicu atau memperparah risiko Kanker Payudara — tetapi benarkah itu fakta atau hanya mitos? Dalam artikel ini kami mengupas dengan seksama bukti ilmiah terbaru, menjawab keraguan Anda, dan membantu Anda membuat pilihan makan yang lebih percaya diri dan tenang.

You may have been avoiding certain foods out of fear that they would trigger or worsen breast cancer — but is that based on fact or myth? In this article we closely examine the latest scientific evidence, answer your doubts, and help you make food choices with confidence and calm.

Apakah Selama Ini Anda Takut Makan Ini Karena Kanker Payudara? Baca Dulu Faktanya!

Have You Been Afraid to Eat This Because of Breast Cancer? Read the Facts First!

Usia muda bukan lagi jaminan bebas dari kanker payudara. Temukan pola baru yang mengejutkan, faktor risiko yang berubah, dan bagaimana Anda bisa bertindak cepat untuk melindungi diri.

Young age is no longer a guarantee of being safe from breast cancer. Discover the shocking new pattern, shifting risk factors, and how you can act quickly to protect yourself.

Apa yang Sebenarnya Terjadi dengan Kanker Payudara Usia Muda? Begini Pola Barunya

What’s Really Happening with Young-Age Breast Cancer? Here Is the New Pattern

Tubuh Anda bisa melawan sel abnormal dengan bantuan makanan bernutrisi tinggi — dan Ini Bukan Mitos. temukan daftarnya di artikel ini.

Your body can fight abnormal cells with nutrient-rich foods — and It's Not a Myth. Find the list in this article.

Tubuh Anda Ternyata Punya Cara Melawan Sel Abnormal Payudara, Tapi Hanya Jika Mendapatkan Nutrisi Ini

Your Body Actually Has a Way to Fight Abnormal Breast Cells, But Only If It Gets These Nutrients

Ingin tahu mengapa sebagian pasien kanker payudara tak perlu kemoterapi? Artikel ini mengungkap rahasia di balik keputusan medis yang jarang dibahas.

Wondering why some breast cancer patients skip chemotherapy? This article reveals the medical truth behind those decisions.

Mengapa Tidak Semua Penderita Kanker Payudara Butuh Kemoterapi?

Why Don’t All Breast Cancer Patients Need Chemotherapy?

Jika Anda mempertimbangkan untuk menyusui atau sudah menjalaninya, ketahui bagaimana pilihan ini mungkin akan berperan dalam mencegah kanker payudara secara biologis.

If you’re considering breastfeeding or have already done so, discover how this choice might play a biological role in preventing breast cancer.

Menyusui: Benarkah Pilihan Ini Bisa Turunkan Risiko Kanker Payudara?

Breastfeeding: Could This Choice Actually Lower Your Breast Cancer Risk?

Benjolan bukan satu-satunya tanda kanker payudara. Tubuhmu bisa memberi sinyal lewat cara lain.

A lump isn’t the only symptom of breast cancer. Your body might be signaling it differently.

Tidak Ada Benjolan? Bukan Berarti Aman dari Kanker Payudara

No Lump? It Doesn’t Mean You’re Safe from Breast Cancer

Tidak Ada Benjolan? Bukan Berarti Anda Aman dari Kanker Payudara

KALGen Innolab memperkuat komitmennya dalam mendukung terapi presisi kanker paru melalui inovasi pemeriksaan liquid biopsy berbasis teknologi molekuler di acara Siloam Lung 360. Pendekatan ini membantu dokter mendeteksi dan memantau kanker secara lebih cepat, akurat, dan minimal invasif.

KALGen Innolab reinforces its commitment to advancing precision therapy for lung cancer through innovative liquid biopsy technology at the Siloam Lung 360 event. This molecular-based approach enables faster, more accurate, and minimally invasive cancer detection and monitoring.

Mendeteksi yang Tak Terlihat: KALGen Innolab Bawa Inovasi Liquid Biopsy ke Siloam Lung 360

Detecting the Invisible: KALGen Innolab Brings Liquid Biopsy Innovation to Siloam Lung 360

Jangan tunggu muncul benjolan. Ada banyak tanda lain kanker payudara yang sering diabaikan.

Don’t wait for a lump. There are many other breast cancer signs often overlooked.

Tubuhmu Sering Memberi Tanda: Jangan Abaikan Gejala Awal Kanker Payudara Ini

Your Body Sends You Signals: Don’t Ignore These Early Signs of Breast Cancer

Banyak yang percaya bra ketat bisa menyebabkan kanker payudara, tapi benarkah demikian? Temukan penjelasan medis dan fakta ilmiah di balik mitos ini agar kamu tidak salah kaprah lagi.

Many believe that tight bras can cause breast cancer — but is it true? Discover the medical explanation and scientific facts behind this common myth so you won’t be misled again.

Benarkah Bra Ketat Bisa Sebabkan Kanker Payudara? Inilah Fakta yang Sebenarnya

Is It True That Tight Bras Can Cause Breast Cancer? Here Are the Real Facts

KALGen Innolab menghadirkan inovasi Comprehensive Genomic Profiling (CGP) KOC559 di ROICAM-12, membuka era baru terapi presisi kanker paru. Temukan bagaimana analisis genomik menyeluruh ini membantu dokter menentukan terapi target dan imunoterapi yang paling efektif bagi setiap pasien.

KALGen Innolab introduces the Comprehensive Genomic Profiling (CGP) KOC559 at ROICAM-12, marking a new era of precision lung cancer therapy. Discover how this broad genomic analysis helps doctors select the most effective targeted and immunotherapy treatments for each patient.

KALGen Innolab Bawa Inovasi Comprehensive Genomic Profiling (CGP) ke ROICAM-12: Mendukung Era Terapi Presisi Kanker Paru

KALGen Innolab Brings Comprehensive Genomic Profiling (CGP) Innovation to ROICAM-12: Supporting the Era of Precision Therapy for Lung Cancer

Gen Anda mungkin menyimpan risiko kanker, tapi itu bukan akhir cerita. KAL-Screen memberi Anda informasi dan langkah pencegahan yang tepat

Your genes may carry cancer risk, but that’s not the end of the story. KAL-Screen gives you the knowledge and prevention steps you need.

Apakah Gen Anda Membawa Risiko Kanker? Saatnya Cari Jawaban dengan KAL-Screen

Do Your Genes Carry a Cancer Risk? It’s Time to Find the Answer with KAL-Screen

Hari Stroke Sedunia jadi momen tepat untuk mengenal fakta sebenarnya tentang stroke. Jangan terkecoh mitos, lindungi diri sejak dini!

On World Stroke Day, uncover the truth about stroke. Skip the myths, know the facts, and safeguard your health early!

Advisory Board

Andi Utama, PhD

Chairman of KALGen Academia

Kata Pengantar

Dr. dr. Samuel JohnyHaryono, Sp.B (K)Onk

Dr. dr. Abas Suherli, SpPK(K)

dr. Heriawaty Hidajat, Sp.PA, SubspKv.R.M (K)

Dr. dr. Fiastuti Witjaksono, MSc, MS, SpGK(K)

Drh. Safarina Golfiani Malik, MS., Ph.D.

dr. Herawati Sudoyo, M.S., Ph.D.

Events

Penelitian & Publikasi

Sitemap

Alamat

Jam Walk In Service

Jam Home Service

Phone

Email

Kalgen Academia